Loading viewer...
investor_presentation
Format: PDF investor_presentation
Fortress Biotech is a clinical-stage biopharmaceutical company with a diversified portfolio spanning dermatology, rare disease, rheumatology, and oncology. The company markets eight dermatology products and develops multiple product candidates across preclinical, clinical, and late-stage development, including gene therapies and CAR-T technologies. Fortress maintains economic interests in majority-owned partners and other affiliated companies with various therapeutic modalities.
presentation
investor_presentation
24 Pages
Tennant Company
Regeneron Pharmaceuticals Investor Presentation — September 2022
investor_presentationinvestor_presentation
42 Pages
Regeneron Pharmaceuticals, Inc.
BriaCell Therapeutics Investor Presentation 2021
investor_presentationinvestor_presentation
17 Pages
BriaCell Therapeutics Corp.